1.
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-...
by Poulter, Neil R
The Lancet (British edition), 2005, Vol.366 (9489), p.907-913
2.
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study
by Farzadfar, Farshad, MD
The Lancet (British edition), 2012, Vol.379 (9810), p.47-54
3.
Defining outcomes for beta cell replacement therapy: a work in progress
by Piemonti, Lorenzo
Diabetologia, 2018, Vol.61 (6), p.1273-1276
4.
Association of rs9939609 Polymorphism with Metabolic Parameters and FTO Risk Haplotype Among Tunisian Metabolic Syndrome
by Elouej, Sahar
Metabolic syndrome and related disorders, 2016, Vol.14 (2), p.121-128
5.
Fresh-Frozen Plasma as a Source of Exogenous Insulin-Like Growth Factor-I in the Extremely Preterm Infant
by Hansen-Pupp, Ingrid
The journal of clinical endocrinology and metabolism, 2009, Vol.94 (2), p.477-482
6.
Genomewide Search for Type 2 Diabetes Mellitus Susceptibility Loci in Finnish Families: The Botnia Study
by Lindgren, C.M
American journal of human genetics, 2002, Vol.70 (2), p.509-516
7.
Intensive glucose control and macrovascular outcomes in type 2 diabetes
by Turnbull, F. M
Diabetologia, 2009, Vol.52 (11), p.2288-2298
8.
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
by Bolinder, Jan, Prof
The Lancet (British edition), 2016, Vol.388 (10057), p.2254-2263
9.
Accessing analytes in biofluids for peripheral biochemical monitoring
by Heikenfeld, Jason
Nature biotechnology, 2019, Vol.37 (4), p.407-419
10.
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies wi...
by Danaei, Goodarz, MD
The Lancet (British edition), 2011, Vol.378 (9785), p.31-40
11.
Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome
by Lindén Hirschberg, A
Gynecological endocrinology, 2004, Vol.19 (2), p.79-87
12.
Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up
by Ärnlöv, Johan
The American heart journal, 2001, Vol.142 (4), p.720-724
13.
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
by Fedchuk, L.
Alimentary pharmacology & therapeutics, 2014, Vol.40 (10), p.1209-1222
14.
Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
by Murphy, Helen R
Diabetologia, 2019, Vol.62 (7), p.1123-1128
15.
Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study
by Lowe, William L
Diabetologia, 2019, Vol.62 (4), p.598-610
16.
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
by UK Hypoglycaemia Study Group
Diabetologia, 2007, Vol.50 (6), p.1140-1147
17.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
by Sarwar, N
The Lancet (British edition), 2010, Vol.375 (9733), p.2215-2222
18.
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
by Feig, Denice S
The Lancet (British edition), 2017, Vol.390 (10110), p.2347-2359
19.
Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts
by Alyass, Akram
Diabetologia, 2014, Vol.58 (1), p.87-97
20.
Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study
by Kontis, Vasilis, PhD
The Lancet (British edition), 2014, Vol.384 (9941), p.427-437
